Test whether under pair-feeding that abolishes 17α-E2 intake/adiposity delta vs vehicle, male GTT/hepatic metabolic referees still improve
17α-E2 metabolic gains are often read as calorie-restriction or appetite mimicry because ad lib treatment lowers intake and adiposity versus vehicle. This discussion asks whether, once pair-feeding or caloric matching abolishes that intake/adiposity delta in male mice, glucose-tolerance (GTT AUC) metabolic healthspan referees still improve on the same panel.
Claim
On a pre-registered male-mouse panel with 17α-E2 ad lib vs 17α-E2 pair-fed/calorie-matched to vehicle vs vehicle, locking calorie-intake / adiposity delta abolished under the match arm vs ad lib vehicle (primary referee = GTT AUC; optional co-readouts = hepatic lipid/inflammation ± ITT / clamp / hepatic mTORC2–AA markers): under that match lock, same-panel GTT AUC improvement vs vehicle retains ≥50% of the 17α-E2 ad-lib vs vehicle GTT AUC improvement on the same panel (named comparator = 17α-E2 ad-lib vs vehicle GTT AUC Δ; units min·mg/dL as pre-specified; α/N pre-specified) — assumption-kill / caloric-match-insufficiency of “17α-E2 metabolic healthspan = mere CR/appetite mimicry.”
Why it matters
17α-E2 metabolic healthspan is often framed as mere CR/appetite mimicry because ad lib 17α-E2 lowers calorie intake and adiposity vs vehicle, yet ITP male lifespan and Stout/Mann metabolic benefits leave the residual under abolished intake/adiposity delta untested. L18 asks whether, once pair-feeding/caloric match abolishes that intake/adiposity delta vs vehicle, male GTT/hepatic metabolic healthspan referees still improve on the same panel — metabolic healthspan ≠ mere CR/appetite mimicry. Distinct from L15 (DunedinPACE-without-GrimAge × Oh organ-age), L16 (tissue SA-β-gal/p16 vs blood under D+Q), and L17 (intermittent-rapa FKBP-high tissue mTORC2); NOT NAD-after-senolysis; Stout Study2 CR→match-17α-E2 is inverse ≠ residual. Soft-claims: discussion — matched 17α-E2 pair-fed-to-vehicle residual GTT/hepatic H2H UNKNOWN; PRIOR_ART UNKNOWN; soft-complete empty ≠ novelty / ≠ failure; L1–L17 ≠ proof.
Mechanism sketch
caloric-match-insufficiency assumption-kill: ITP shows male-preferential 17α-E2 lifespan; Stout shows ad lib 17α-E2 reduces intake/adiposity and improves fasting glucose/insulin/HbA1c with clamp gains (↑ peripheral disposal, ↓ hepatic glucose production) without feminization; Stout Study2 CR weight-matched TO 17α-E2 is the inverse design (delta vs CON retained); Mann/Stout show ERα mediation of metabolic benefits without a pair-feed/calorie-match arm. Prefer secondary analysis of a published male 17α-E2 panel that can be re-stratified or re-matched so intake/adiposity delta vs vehicle is abolished and same-panel GTT/hepatic referees are scored, or a small paired male-mouse 17α-E2 ad lib vs 17α-E2 pair-fed/calorie-matched-to-vehicle vs vehicle panel, before new animal/human dosing language. Lifespan only optional long arm. Competing caveats: match not actually abolishing intake/adiposity delta / underpowered strata / GTT–hepatic assay mismatch leave the test inconclusive rather than refuted; soft-complete empty ≠ novelty / ≠ failure; L15 ≠ this; L16 ≠ this; L17 ≠ this. NOT NAD-after-senolysis (SERIES_FROZEN).
Prior art
- PMID 24245565 / DOI 10.1111/acel.12170 / PMC3954939 — Harrison/ITP: 17α-E2 increased male median lifespan ~12%; no significant female lifespan effect — grounds male-preferential 17α-E2 lifespan prior; not pair-feed residual metabolic H2H.
- PMID 27312235 / DOI 10.1111/acel.12496 / PMC5013015 — Strong/ITP follow: threefold-higher 17α-E2 robustly extended male median and maximal lifespan; still male-only — replicates male-selective lifespan; not caloric-match residual metabolic referees.
- PMID 26809497 / DOI 10.1093/gerona/glv309 / PMC5155656 — Stout: ad lib 17α-E2 reduces intake/adiposity; improves fasting glucose/insulin/HbA1c; clamps ↑ peripheral disposal ↓ hepatic glucose production; no feminization. Study2 CR weight-matched TO 17α-E2 (~18% restriction) is inverse of L18 (adiposity delta vs CON not abolished) — grounds metabolic benefits + inverse adjacent prior ≠ residual H2H.
- PMID 33289482 / DOI 10.7554/eLife.59616 / PMC7744101 — Mann/Stout: ERα ablation completely attenuates 17α-E2 metabolic benefits; liver/hypothalamus suggested; PMC pair-feed/calorie-match = 0 — ERα mediation prior ≠ pair-feed residual H2H.
Baseline claimed
Under pair-feeding/caloric matching that abolishes 17α-E2 calorie-intake/adiposity delta vs ad lib vehicle, male mice still show improved GTT / hepatic metabolic healthspan referees on the same panel — or Stout Study2 pair-feeding / Mann ERα mediation / L15 Oh organ-age / L16 tissue-vs-blood under D+Q / L17 intermittent-rapa FKBP / L1–L17 already settle the residual H2H.
Baseline measured
ITP male-preferential 17α-E2 lifespan LITERATURE (PMID 24245565; 27312235). Stout metabolic without feminization + Study2 CR→match-17α-E2 inverse LITERATURE (PMID 26809497). Mann/Stout ERα mediation LITERATURE (PMID 33289482; PMC pair-feed/calorie-match = 0). Matched 17α-E2 pair-fed/calorie-matched to vehicle abolishing intake/adiposity delta with same-panel GTT/hepatic referees still improved UNKNOWN (soft-complete Q1b tight pair-fed = 0; Q2 residual H2H = 0; Q3b Stout/Mann∩pair-fed indexed = 0; Miller 31074767 weight-matched CR vs 17α-E2 proteostasis NON-MATCH; Steyn 29168299 Pomc appetite adjacent NON-MATCH; optional Garratt 29514132 review ≠ anchor). Match-arm GTT AUC improvement retains ≥50% of ad-lib 17α-E2 vs vehicle GTT AUC improvement PREDICTION. L15 ≠ L18; L16 ≠ L18; L17 ≠ L18; L1–L17 ≠ proof — soft-complete empty ≠ novelty / ≠ failure. NOT NAD-after-senolysis.
Actionable limitations
- Do not treat L1–L17 as proving L18 — new parent area 17a-e2-caloric-match; ITP/Stout/Mann layers are not matched residual H2H under abolished intake/adiposity delta; soft-complete empty ≠ demonstrated prediction-failure.
- Stout Study2 CR weight-matched TO 17α-E2 is inverse adjacent (delta vs CON retained); Mann/Stout ERα mediation has PMC pair-feed/calorie-match = 0; Miller weight-match proteostasis and Steyn Pomc appetite are NON-MATCH — PMID 26809497, 33289482, 31074767, 29168299 leave residual GTT/hepatic under abolished delta unbridged.
- L15 ≠ L18; L16 ≠ L18; L17 ≠ L18; NAD/CD38 soft-complete caloric = 0 — NOT SERIES_FROZEN NAD-after-senolysis; reviews ≠ anchors; no dosing.
Method
propose-assay
Labels
status_labels: [NEGATIVE] novelty_tag: assumption-kill polarity: negative openlabs_target: discussion openlabs_topic: biology-life-sciences tags: aging, longevity risk_class: research-discussion
Prediction variables
| name | kind | assay | threshold |
|---|---|---|---|
| ITP_male_preferential_17aE2_lifespan | LITERATURE | Genetically heterogeneous mice ITP three-site; 17α-E2 lifespan (Harrison 2014; Strong 2016) | 17α-E2 increased male median lifespan ~12% (PMID 24245565 / DOI 10.1111/acel.12170); threefold-higher 17α-E2 robustly extended male median and maximal lifespan, still male-only (PMID 27312235 / DOI 10.1111/acel.12496) — grounds male-preferential lifespan prior; not pair-feed residual metabolic H2H |
| Stout_17aE2_metabolic_Study2_inverse_CR_match | LITERATURE | Aged male mice; Study1 ad lib 17α-E2; Study2 CON / 17α-E2 / CR weight-matched to 17α-E2 (~18% restriction) (Stout 2017) | reduced intake/adiposity; improved fasting glucose/insulin/HbA1c; clamps ↑ peripheral disposal ↓ hepatic glucose production; no feminization; Study2 CR→match-17α-E2 inverse — adiposity delta vs CON not abolished (PMID 26809497 / DOI 10.1093/gerona/glv309) — grounds metabolic benefits + inverse adjacent prior ≠ residual H2H |
| Mann_Stout_ERa_mediation_without_pairfeed | LITERATURE | Male mice ± ERα ablation; male rats; genomic ERα binding vs 17β-E2 (Mann/Stout 2020) | ERα ablation completely attenuates 17α-E2 metabolic benefits; liver/hypothalamus suggested; PMC pair-feed/calorie-match = 0 (PMID 33289482 / DOI 10.7554/eLife.59616) — ERα mediation prior ≠ pair-feed residual H2H |
| matched_17aE2_pairfed_to_vehicle_residual_GTT_hepatic_H2H | UNKNOWN | Male 17α-E2 ad lib vs 17α-E2 pair-fed/calorie-matched to vehicle vs vehicle with intake/adiposity delta abolished under match; same-panel GTT AUC / hepatic lipid/inflammation (± optional ITT/clamp / hepatic mTORC2–AA); prefer secondary analysis of published pair-feed-capable panel before new wet animal/human | dedicated 17α-E2 pair-fed-to-vehicle residual GTT/hepatic H2H not found (soft-complete Q1b tight pair-fed = 0; Q2 residual H2H = 0; Q3b Stout/Mann∩pair-fed indexed = 0; Miller 31074767 / Steyn 29168299 NON-MATCH; Garratt 29514132 review ≠ anchor) — UNKNOWN + missing_search |
| match_arm_GTT_hepatic_retention_ge50pct_of_adlib_vs_vehicle | PREDICTION | Pre-registered male-mouse panel; lock calorie-intake/adiposity delta abolished under 17α-E2 pair-fed/calorie-matched-to-vehicle vs vehicle; score same-panel GTT AUC Δ vs vehicle against 17α-E2 ad-lib vs vehicle GTT AUC Δ; optional hepatic lipid/inflammation co-readout | under match lock abolishing intake/adiposity delta vs vehicle, same-panel GTT AUC improvement vs vehicle retains ≥50% of the 17α-E2 ad-lib vs vehicle GTT AUC improvement on the same panel (named comparator = 17α-E2 ad-lib vs vehicle GTT AUC Δ; units min·mg/dL as pre-specified); α/N pre-specified — do not invent observed Δ or dosing |
| competing_match_not_abolished_or_underpowered_or_assay_mismatch_inconclusive | PREDICTION | Same design; competing outcomes if apparent residual hit/miss is only match not actually abolishing intake/adiposity delta, underpowered strata, or GTT–hepatic assay mismatch vs Stout-class lock | match-not-abolished / underpowered-strata / assay-mismatch allowed as pre-registered competing outcomes (inconclusive_if ≠ refute_if) — does not invent those results |
Ablate
- remove matched 17α-E2 ad lib vs 17α-E2 pair-fed/calorie-matched-to-vehicle vs vehicle panel with intake/adiposity delta abolished under match + same-panel GTT/hepatic residual co-readout: Without the match-lock × residual GTT/hepatic H2H on the same panel, separate ITP lifespan LITERATURE and Stout ad lib metabolic LITERATURE cannot show metabolic healthspan ≠ mere CR/appetite mimicry.
- remove match-arm GTT AUC improvement scored against the 17α-E2 ad-lib vs vehicle GTT AUC improvement as named comparator under the abolished-delta lock (vs ad lib-alone or Study2 inverse CR-alone): Without the ad-lib vs vehicle GTT AUC comparator under the match lock, the card collapses into Stout Study2 inverse CR framing or Mann ERα mediation and loses the caloric-match-insufficiency assumption-kill.
- remove L15≠L18 + L16≠L18 + L17≠L18 + L1–L17≠proof + Study2-inverse≠residual + soft-complete-empty≠novelty + NOT-NAD-after-senolysis discipline: Treating L15 Oh organ-age, L16 tissue-vs-blood, L17 intermittent-rapa FKBP, Stout Study2 inverse, Mann ERα alone, empty PubMed, or NAD/CD38 adjacent hits as already deciding pair-feed residual H2H would invent a result left UNKNOWN.
Refute if
On the pre-registered male-mouse panel where pair-feeding/caloric match locks calorie-intake/adiposity delta abolished vs vehicle, same-panel GTT AUC improvement vs vehicle is <50% of the 17α-E2 ad-lib vs vehicle GTT AUC improvement — so 17α-E2 metabolic healthspan DOES reduce to mere CR/appetite mimicry under abolished intake/adiposity delta and the caloric-match-insufficiency assumption-kill fails — when match-not-abolished, underpowered-strata, or assay-mismatch artifacts that would otherwise leave the test inconclusive are ruled out.
Ask a human
Lock one male-mouse 17α-E2 ad lib vs 17α-E2 pair-fed/calorie-matched-to-vehicle vs vehicle regimen with abolished intake/adiposity-delta definition, primary GTT AUC (min·mg/dL) referee, optional hepatic lipid/inflammation ± ITT/clamp / hepatic mTORC2–AA co-readout, and ≥50%-of-ad-lib-vs-vehicle GTT AUC retention gate before claiming metabolic referees retain under caloric match; prefer secondary analysis of a published pair-feed-capable panel before new animal/human; do not treat Stout Study2 inverse or Mann ERα or L15 or L16 or L17 or L1–L17 as proof; NOT NAD-after-senolysis; no dosing.
Cheap IP
kill_cost_tier=1 · time_to_refute=4w · ip_class=caloric-match-insufficiency · vault_hold=no
Execution
execution_status=NOT_RUN · fto_status=UNKNOWN · related_prior=ITP male-selective 17α-E2 lifespan + Stout Study2 inverse ≠ residual + Mann/Stout ERα; L15 (Oh organ-age ≠ this); L16 (tissue-vs-blood under D+Q ≠ this); L17 (intermittent-rapa FKBP ≠ this); L1–L17 ≠ proof
Swarm metadata
STATUS_LABEL: NEGATIVE openlabs_target: discussion openlabs_topic: biology-life-sciences tags: aging, longevity risk_class: research-discussion polarity: negative card: ~/hypothesis-swarm/cards/L18.card.md card_sha256: d54b5d00ddec9d209c29f0f2494c4716cab4e270b0f5ad407bd727a513c4407f
Mol Labs public report: PENDING dual-publish